Literature DB >> 17676323

Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning.

Qing-An Yuan1, Matthew K Robinson, Heidi H Simmons, Maria Russeva, Gregory P Adams.   

Abstract

While cell surface antigens represent the most common targets for antibody-based cancer therapy, isolation of new antibodies specific for these targets from single-chain Fv phage display libraries has been hindered by limitations associated with traditional selection techniques. Solid phase panning is often associated with conformational changes to the target protein due to its immobilization on plastic tubes that can limit the ability of the isolated scFv to bind to conformational epitopes and solution panning methods require the use of secondary tags that often mask desired sequences and create unintended epitopes. Commonly utilized cell-based panning methods typically yield a panel of single-chain Fv (scFv) molecules that are specific for numerous cell surface antigens, often obscuring the desired clones. Here, we describe a novel cell sorter-based system to isolate single-chain Fv molecules specific for defined antigen targets expressed on stably-transformed mammalian cells. We employed these methods to isolate promising scFv clones that bind specifically to the Müllerian inhibiting substance type II receptor, a cell surface ovarian cancer antigen that has proven to be a difficult target for selection strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17676323     DOI: 10.1007/s00262-007-0376-2

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  9 in total

1.  CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies.

Authors:  Alba Rodriguez-Garcia; Prannda Sharma; Mathilde Poussin; Alina C Boesteanu; Nicholas G Minutolo; Sarah B Gitto; Dalia K Omran; Matthew K Robinson; Gregory P Adams; Fiona Simpkins; Daniel J Powell
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

2.  Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Authors:  Juan Carlos Almagro; Gary L Gilliland; Felix Breden; Jamie K Scott; Devin Sok; Matthias Pauthner; Janice M Reichert; Gustavo Helguera; Raiees Andrabi; Robert Mabry; Mathieu Bléry; James E Voss; Juha Laurén; Lubna Abuqayyas; Stefan Barghorn; Eshel Ben-Jacob; James E Crowe; James S Huston; Stephen Albert Johnston; Eric Krauland; Fridtjof Lund-Johansen; Wayne A Marasco; Paul W H I Parren; Kai Y Xu
Journal:  MAbs       Date:  2014-03-03       Impact factor: 5.857

3.  Tailoring subtractive cell biopanning to identify diffuse gastric adenocarcinoma-associated antigens via human scFv antibodies.

Authors:  Tayebeh Mehdipour; Mohammad R Tohidkia; Amir Ata Saei; Amir Kazemi; Shirin Khajeh; Ali A Rahim Rahimi; Sepideh Nikfarjam; Mehrdad Farhadi; Monireh Halimi; Ramin Soleimani; Roman A Zubarev; Mohammad Nouri
Journal:  Immunology       Date:  2019-11-08       Impact factor: 7.397

4.  Targeting acute myeloid cell surface using a recombinant antibody isolated from whole-cell biopanning of a phage display human scFv antibody library.

Authors:  Thitima Sumphanapai; Kerry Chester; Surasak Sawatnatee; Jenny Yeung; Montarop Yamabhai
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

5.  Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.

Authors:  Lily Yang; Hui Mao; Y Andrew Wang; Zehong Cao; Xianghong Peng; Xiaoxia Wang; Hongwei Duan; Chunchun Ni; Qingan Yuan; Gregory Adams; Mark Q Smith; William C Wood; Xiaohu Gao; Shuming Nie
Journal:  Small       Date:  2009-02       Impact factor: 13.281

6.  Label-free, all-electrical, in situ human epidermal growth receptor 2 detection.

Authors:  Joseph A Capobianco; Wan Y Shih; Qing-An Yuan; Gregory P Adams; Wei-Heng Shih
Journal:  Rev Sci Instrum       Date:  2008-07       Impact factor: 1.523

7.  Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival.

Authors:  Maëva Chauvin; Véronique Garambois; Sylvie Choblet; Pierre-Emmanuel Colombo; Myriam Chentouf; Laurent Gros; David-Paul De Brauwere; Martine Duonor-Cerutti; Karen Dumas; Bruno Robert; Marta Jarlier; Pierre Martineau; Isabelle Navarro-Teulon; David Pépin; Thierry Chardès; André Pèlegrin
Journal:  Int J Oncol       Date:  2021-05-20       Impact factor: 5.650

8.  Targeting membrane proteins for antibody discovery using phage display.

Authors:  Martina L Jones; Mohamed A Alfaleh; Sumukh Kumble; Shuo Zhang; Geoffrey W Osborne; Michael Yeh; Neetika Arora; Jeff Jia Cheng Hou; Christopher B Howard; David Y Chin; Stephen M Mahler
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

9.  Phage display library selection of a hypoxia-binding scFv antibody for liver cancer metabolic marker discovery.

Authors:  Jing Liu; Qing Zhang; Hang Chen; Zhihui Gao; Yao Li; Zhongyuan Sun; Rong Xiang; Sihe Zhang
Journal:  Oncotarget       Date:  2016-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.